Pacira

Pacira Pharmaceuticals develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers. Read more

David Stack's photo - Chairman & CEO of Pacira

Chairman & CEO

David Stack

CEO Approval Rating

82/100

Founded:

2006

Status:

PublicIndependent CompanyNASDAQPCRX

PACIRA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Innocoll is the top competitor of Pacira. Innocoll is a Private company that was founded in Newtown Square, Pennsylvania in 1985. Like Pacira, Innocoll also operates in the Pharmaceuticals sector. Innocoll has 413 fewer employees vs. Pacira.

Cadence Pharmaceuticals is seen as one of Pacira's biggest rivals. Cadence Pharmaceuticals was founded in San Diego, California} in 2004. Like Pacira, Cadence Pharmaceuticals also competes in the Pharmaceuticals space. Compared to Pacira, Cadence Pharmaceuticals generates $330.4M less revenue.

Eli Lilly is perceived as one of Pacira's biggest rivals. Eli Lilly was founded in 1876, and is headquartered in Indianapolis, Indiana. Like Pacira, Eli Lilly also operates in the Pharmaceuticals space. Eli Lilly generates $25B more revenue vs. Pacira.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Iroko a competitor of Pacira?

Pacira Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$443M

Pacira's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 2.4B. Over the last four quarters, Pacira's revenue has grown by 57.6%. Specifically, in Q1 2021's revenue was $119M; in Q4 2020, it was $131M; in Q3 2020, it was $117.5M; in Q2 2020, Pacira's revenue was $75.5M.

Pacira Acquisitions

No recent acquisitions found related to Pacira

Pacira Funding History

Since Pacira was founded in 2006, it has participated in 1 round of funding. In total Pacira has raised $42.0M. Pacira's funding round was on Feb 2011 for a total of $42.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Feb 2011
$42M
-

Since Pacira was founded in 2006, it has participated in 1 round of funding. In total Pacira has raised $42.0M. Pacira's funding round was on Feb 2011 for a total of $42.0M

Pacira Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$3M
Apr 19, 2021
Convertible Note
-
GeneQuine develops novel therapies for degenerative joint diseases.
$6.6M
Jan 25, 2021
Series A
-
Avalon develops an AI-based platform that offers data analytics, contract tracing and communication solutions for education and healthcare sectors.
$1.5M
Aug 24, 2020
Seed
-

Pacira News

May 26, 2021Benzinga

Pacira BioSciences' Exparel Misses Primary Endpoint In Post-Op Pain Study After Lower Extremity Surgeries

Pacira BioSciences Inc (NASDAQ: PCRX) has announced topline results from its Phase 3 STRIDE study eva... See more »
April 27, 2021Global Legal Chronicle

Pacira Biosciences' $3M Investment in Spine BioPharma

Troutman Pepper Hamilton Sanders LLP advised Spine BioPharma, LLC on the deal. Spine BioPharma, LLC, ... See more »
April 20, 2021BioSpace

Spine BioPharma Announces Investment by Pacira Biosciences

Spine BioPharma, LLC, a company committed to developing non-opiate, non-surgical therapies for the tr... See more »
April 20, 2021Becker's Spine Review

Pacira invests in biopharmaceutical company

Pacira Biosciences invested $3 million in Spine BioPharma.... See more »
April 15, 2021STAT News

A drug maker sues a medical journal, its editor, and several authors for libel

Pacira Biosciences claimed the journal published "faulty scientific research" and as a result, its me... See more »

Pacira Press Releases

May 25, 2021GlobeNewswire

Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference

PARSIPPANY, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today anno... See more »
May 11, 2021GlobalNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021

April 2021 EXPAREL average daily sales were 449% of April 2020 April 2021 EXPAREL average daily sales... See more »
May 4, 2021GlobeNewswire

Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update

-- EXPAREL average daily sales at 115% of the prior year first quarter---- Conference call today at 8... See more »
April 21, 2021StreetInsider

Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021

PARSIPPANY, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today an... See more »
April 14, 2021GlobalNewswire

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

Complaint challenges the American Society of Anesthesiologists for promoting biased, analytically mis... See more »
April 7, 2021GlobeNewswire

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

EXPAREL average daily sales at 115% of the prior year for the first quarter and 137% of the prior yea... See more »
March 9, 2021GlobalNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

-- EXPAREL average daily sales at 103% of the prior year for the month of February 2021 -- PARSIPPANY... See more »

Social Media

Pacira Headquarters

5 Sylvan Way

Parsippany, New Jersey07054

973-254-3560

Driving Directions »

Trending Companies

Pacira Summary

ABOUT

Overview

Pacira Pharmaceuticals develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers. Pacira was founded in 2006. Pacira's headquarters is located in Parsippany, New Jersey, USA 07054. It has ra...

CEO

Pacira's Chairman & CEO, David Stack, currently has an approval rating of 82%. Pacira's primary competitors are Innocoll, Cadence Pharmaceuticals & Eli Lilly.

Website

pacira.com

Frequently Asked Questions about Pacira

  1. When was Pacira founded?

    Pacira was founded in 2006
  2. Who is Pacira's CEO?

    Pacira's CEO is David Stack
  3. How much revenue does Pacira generate?

    Pacira generates $443M in revenue
  4. How much funding does Pacira have?

    Pacira has historically raised $42M in funding
  5. Where is Pacira's headquarters?

    Pacira's headquarters is in Parsippany New Jersey, USA
  1. How many employees does Pacira have?

    Pacira has 518 employees
  2. What sector does Pacira operate in?

    Pacira is in Pharmaceuticals
  3. Who are Pacira's competitors?

    Pacira's top competitors are Innocoll, Cadence Pharmaceuticals, Eli Lilly
  4. Who has Pacira invested in?

    Pacira's has invested in companies such as Spine BioPharma, GeneQuine, Avalon.ai